1 to 10 of 132 literature results

• Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

  BACKGROUND: Laser treatment for diabetic retinopathy is often associated with visual field reduction and other ocular side-effects. Our aim was to ass…

  Authors: A C Keech, P Mitchell, P A Summanen, J O'Day, T M E Davis, M S Moffitt, M-R Taskinen, R J Simes, D Tse, E Williamson,…

  Source: Lancet. 2007 Nov 17

  View Full Text

• Axonal loss and myelin in early ON loss in postacute optic neuritis.

  OBJECTIVE: To investigate the relation between retinal nerve fiber layer (RNFL) thickness and latency and amplitude of multifocal visual-evoked potent…

  Authors: Alexander Klistorner, Hemamalini Arvind, Than Nguyen, Raymond Garrick, Mark Paine, Stuart Graham, Justin O'Day, John Grigg, Francis Billson, Con Yiannikas

  Source: Annals of neurology. 2008 Sep

  View Full Text

• mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.

  BACKGROUND: The detection of circulating tumor cells (CTCs) in the peripheral blood of melanoma patients by quantitative real-time reverse-transcripti…

  Authors: Minoru Kitago, Kazuo Koyanagi, Takeshi Nakamura, Yasufumi Goto, Mark Faries, Steven J O'Day, Donald L Morton, Soldano Ferrone, Dave S B Hoon

  Source: Clinical chemistry. 2009 Apr

  View Free Full Text

• Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.

  Although previous studies have separately shown the utility of circulating tumor cells (CTC) or cell-free tumor-related DNA in blood of cancer patient…

  Authors: Kazuo Koyanagi, Takuji Mori, Steven J O'Day, Steve R Martinez, He-Jing Wang, Dave S B Hoon

  Source: Cancer research. 2006 Jun 15

  View Full Text

• Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma.

  Although biochemotherapy appears to be a promising treatment for metastatic melanoma, its impact remains unpredictable. Microsatellite markers for los…

  Authors: Bret Taback, Steven J O'Day, Peter D Boasberg, Sherry Shu, Patricia Fournier, Robert Elashoff, He-Jing Wang, Dave S B Hoon

  Source: Journal of the National Cancer Institute. 2004 Jan 21

  View Full Text

• A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.

  BACKGROUND: nab-Paclitaxel (ABI-007, Abraxane), a 130-nM, albumin-bound (nab) particle form of Cremophor-free paclitaxel, is approved for metastatic b…

  Authors: Evan M Hersh, Steven J O'Day, Antoni Ribas, Wolfram E Samlowski, Michael S Gordon, Deganit E Shechter, Alicia A Clawson, Rene Gonzalez

  Source: Cancer. 2010 Jan 1

  View Full Text

• Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.

  Cancer immunotherapy centers on modulating the host's tumor-directed immune response. One promising approach involves augmentation of cell-mediated im…

  Authors: Steven J O'Day, Omid Hamid, Walter J Urba

  Source: Cancer. 2007 Dec 15

  View Full Text

• Estrogen receptor-alpha methylation predicts melanoma progression.

  The role of estrogen receptor alpha (ER-alpha) in melanoma is unknown. ER-alpha expression may be regulated in melanoma via hypermethylation of promot…

  Authors: Takuji Mori, Steve R Martinez, Steven J O'Day, Donald L Morton, Naoyuki Umetani, Minoru Kitago, Atsushi Tanemura, Sandy L Nguyen, Andy N Tran, He-Jing Wang,…

  Source: Cancer research. 2006 Jul 1

  View Full Text

• Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome.

  Allelic imbalance (AI) encompassing the apoptotic protease-activating factor 1 (APAF-1) locus (12q22-23) is found frequently in metastatic melanoma. C…

  Authors: Akihide Fujimoto, Steven J O'Day, Bret Taback, David Elashoff, Dave S B Hoon

  Source: Cancer research. 2004 Jun 15

  View Full Text

• Electrophysiological evidence for heterogeneity of lesions in optic neuritis.

  PURPOSE: To examine the natural history of multifocal visual evoked potentials (mfVEPs) within 12 months of the first episode of optic neuritis (ON) i…

  Authors: Alexander Klistorner, Stuart Graham, Clare Fraser, Raymond Garrick, Tan Nguyen, Michael Paine, Justin O'Day, John Grigg, Hemamalini Arvind, Frank A Billson

  Source: Investigative ophthalmology & visual science. 2007 Oct

  View Full Text